Related Experiment Video

Updated: Jul 11, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

HMGA1a: sequence-specific RNA-binding factor causing sporadic Alzheimer's disease-linked exon skipping of

Takayuki Manabe1, Kenji Ohe, Taiichi Katayama

  • 1Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.

Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|October 2, 2007
PubMed

Insights

High mobility group A protein 1a (HMGA1a) drives aberrant exon skipping in presenilin-2 (PS2) pre-mRNA, producing a toxic PS2V protein linked to Alzheimer's disease. Inhibiting HMGA1a binding prevents this skipping and protects against cell death.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • Aberrant splicing of presenilin-2 (PS2) pre-mRNA generates the PS2V isoform, found in sporadic Alzheimer's disease (AD) brains.
  • PS2V overexpression increases endoplasmic reticulum (ER) stress susceptibility and amyloid-beta production.
  • High mobility group A protein 1a (HMGA1a) was previously identified as a factor causing aberrant exon 5 skipping.

Purpose of the Study:

  • To elucidate the molecular mechanism by which HMGA1a induces aberrant exon 5 skipping in PS2 pre-mRNA.
  • To investigate the role of the HMGA1a-binding sequence in regulating splice site inactivation.
  • To evaluate the therapeutic potential of inhibiting HMGA1a-mediated exon skipping.

Main Methods:

  • Demonstration of HMGA1a's role using heterologous pre-mRNAs and analysis of HMGA1a-binding sequences.
  • Detection of HMGA1a-U1 snRNP complexes during early splicing reactions.
  • In vitro and in vivo experiments using competitor 2'-O-methyl RNA (2'-O-Me RNA) to block HMGA1a binding.

Main Results:

  • A specific HMGA1a-binding sequence in exon 5, adjacent to the 5' splice site, is essential for HMGA1a-mediated splice site inactivation.
  • Aberrant HMGA1a-U1 snRNP complexes were observed at the binding site during splicing.
  • Competitor 2'-O-Me RNA significantly inhibited exon 5 skipping and prevented HMGA1a-induced cell death under ER stress.

Conclusions:

  • HMGA1a binding to a specific sequence in PS2 exon 5 inactivates the 5' splice site, leading to PS2V production and neurotoxicity.
  • Targeting the HMGA1a-binding site with RNA-based inhibitors offers a potential therapeutic strategy for PS2V-associated neurodegenerative diseases.

More Related Videos

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae07:14

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae

Published on: February 25, 2022

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...